When I initially bought into RVX prior to the Zenith spinoff I understood that we had AT LEAST an 8 year lead on our competitors in the epigenetics field.  Now, oh so many years later, do we still have a lead?

Science has not stood still waiting for Don and RVX to get their $#!* together.  Unfortunately RVX seems to be treading water.  I am like many here, too deep to bail and take a big loss, greedy enough to not cut my losses and move on.

 GLTA